Grand Rounds September 16, 2022: Using Nationwide Registries to Conduct Pragmatic Randomized Trials: The DANFLU Program (Tor Biering-Sørensen, MD, PhD, MPH)
Rethinking Clinical Trials
SEPTEMBER 22, 2022
The DANFLU-1 trial is a large-scale pragmatic RCT that looked at high-dose vs standard-dose flu vaccine to test whether high-dose vaccines might reduce hospitalizations among the elderly, age 65 and older. Hospitalization of flu is the primary outcome. Hospitalization of flu is the primary outcome. Key Points.
Let's personalize your content